← FDA DRUG APPROVALS

FDA ANDA · ANDA060781

PENICILLIN G POTASSIUM

Sponsor: MYLAN

APPLICATION
ANDA060781
TYPE
ANDA
ORIGINAL APPROVAL
1980-03-10
LATEST ACTION
1980-03-10
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 500,000 UNITS · TABLET · ORAL
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 400,000 UNITS · TABLET · ORAL
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 200,000 UNITS · TABLET · ORAL
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 800,000 UNITS · TABLET · ORAL
PENICILLIN G POTASSIUMDiscontinued
PENICILLIN G POTASSIUM 250,000 UNITS · TABLET · ORAL

Approval history

1980-03-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →